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venous extracorporeal membrane
oxygenation: a case report
Michihito Kyo, Shinichiro Ohshimo*, Yoshiko Kida, Tatsutoshi Shimatani, Yusuke Torikoshi, Kei Suzuki,
Satoshi Yamaga, Nobuyuki Hirohashi and Nobuaki ShimeAbstract
Background: Venoarterial-venous extracorporeal membrane oxygenation (VAV ECMO) configuration is a combined
procedure of extracorporeal membrane oxygenation (ECMO). The proportion of cardiac and respiratory support can
be controlled by adjusting arterial and venous return. Therefore, VAV ECMO can be applicable as a bridging therapy
in the transition from venoarterial (VA) to venovenous (VV) ECMO.
Case presentation: We present an 11-year-old girl with chemotherapy-induced myocarditis requiring
extracorporeal cardiorespiratory support. She showed progressive hypotension, tachycardia, hyperlactemia, and
tachypnea under support of catecholamines. Echocardiography showed severe left ventricular hypokinesis with an
ejection fraction of 30 %. She was placed on VA ECMO with a drainage catheter from the right femoral vein
(19.5 Fr) and a return catheter to the right femoral artery (16.5 Fr). Extracorporeal circulation was initiated at a blood
flow of 2.0 L/min (59 mL/kg/min). On day 31, although cardiac function had improved, persistent pulmonary failure
made weaning from VA ECMO difficult. We planned transition from VA ECMO to VAV ECMO to ensure gradual
tapering of extracorporeal cardiac support while evaluating cardiopulmonary function. An additional return cannula
(13.5 Fr) was inserted from the right internal jugular vein, which was connected to the circuit branch from the
original returning cannula. We then gradually shifted the blood from the femoral artery to the right internal jugular
vein over 24 h. She was successfully switched from VA to VV ECMO via VAV ECMO.
Conclusions: VAV ECMO might be an option in ensuring oxygenation to the coronary circulation and allowing
time to adequately evaluate cardiac function during transition from VA to VV ECMO. Further investigations using
larger cohorts are necessary to validate the efficacy of VAV ECMO as a bridging therapy in the transition from VA to
VV ECMO.
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Femoral venoarterial extracorporeal membrane oxygen-
ation (VA ECMO) is an important tool for supporting
cardiac function in patients with severe cardiac failure
because of its rapid vascular access [1]. Decreased oxy-
genation for the coronary and right upper body circula-
tion is one of the major disadvantages of femoral VA
ECMO. This condition is particularly obvious in patients
with improvement in left ventricular dysfunction and de-
terioration in pulmonary function. This in turn leads to
deterioration in ventricular function when continuing
VA ECMO. Moreover, accurate evaluation of cardiac
function in patients supported by VA ECMO is some-
times difficult [2]. These factors negatively affect suc-
cessful weaning from VA ECMO.
A VA-venous (VAV) ECMO configuration is a com-
bined procedure in which ECMO enables oxygenated
blood flow to the arterial and venous circulations where
the proportion of flow can be easily controlled [3]. In
this report, we present a pediatric patient with severe
cardiorespiratory failure related to myocarditis who was
managed with VAV ECMO when transitioning from VA
to VV ECMO.
Case presentation
An 11-year-old girl (140 cm in height, 34 kg in weight) was
diagnosed with aplastic anemia and received hematopoietic
stem cell transplantation. However, simultaneous chemo-
therapy using cyclosporin and cyclophosphamide induced
myocarditis, resulting in cardiorespiratory failure. She pre-
sented with tachypnea (32 breaths/min), tachycardia
(124 bpm), and hypotension (98/60 mmHg) on admission
to the intensive care unit. Laboratory tests showed an in-
creased N-terminal pro-B-type natriuretic peptide (NT-
proBNP) level of 10,483 pg/mL (normal, <125 pg/mL) and
hyperlactemia (4.5 mmol/L). A chest radiograph and com-
puted tomography showed bilateral diffuse pulmonary in-
filtrate and pleural effusion.
The hemodynamic state of the patient rapidly deterio-
rated with progressive hypotension (87/54 mmHg),
tachycardia (155 bpm), and hyperlactemia (9.1 mmol/L)
under support of 4 μg/kg/min of dobutamine. Arterial
blood gas analysis showed metabolic acidosis and re-
spiratory alkalosis (pH, 7.453; partial pressure of oxygen
(PaO2), 107 Torr; partial pressure of carbon dioxide
(PaCO2), 27.2 Torr; HCO3
−, 18.7 mmol/L; Fraction of in-
spired oxygen (FIO2), 0.3). Echocardiography showed se-
vere left ventricular hypokinesis with an ejection fraction
of 30 %. She was placed on VA ECMO with centrifuged
pump (CapioxTM, Terumo, Tokyo, Japan). The drainage
catheter was inserted from the right femoral vein to in-
ferior vena cava (IVC, 19.5 Fr), and the return catheter
(16.5 Fr) was inserted from the right femoral artery (FA)
to the abdominal aorta. Extracorporeal circulation wasinitiated at a blood flow of 2.0 L/min (59 mL/kg/min)
and a sweep gas flow of 1.3 L/min with an FIO2 of 1.0.
The cardiorespiratory support with VA ECMO provided
gradual improvement of cardiac function. On day 31,
echocardiography demonstrated an improved left ven-
tricular ejection fraction of 50 %. However, PaO2 of the
right radial artery was 55 mmHg with a blood flow of
4.6 L/min (135 mL/kg/min), which indicated insufficient
pulmonary oxygenation. Pulmonary edema and bilateral
pleural effusion on chest X-ray were still evident. A trial
of reducing extracorporeal blood flow up to 3.7 L/min
(109 mL/kg/min) led to severe hypoxemia (blood oxygen
saturation, 81 %), hypotension (50/30 mmHg), and
bradycardia (60 bpm), making weaning from VA ECMO
difficult. On day 32, the repeated trial of reducing extra-
corporeal blood flow led to severe hypotension and
bradycardia again, despite the improved left ventricular
ejection fraction on echocardiography and the decreased
PaO2 of the right radial artery under extracorporeal sup-
port. We evaluated that the current cardiac function was
yet insufficient without extracorporeal cardiac support,
although prolonged retrograde blood flow of ECMO de-
teriorated an improving left ventricular function.
On day 33, we planned transition from VA ECMO to
VAV ECMO to ensure gradual tapering of extracorporeal
cardiac support, because a direct transition from VA
ECMO to VV ECMO had a potential risk of circulatory
failure. An additional return cannula (13.5 Fr) was
inserted into the right atrium via the right internal jugular
vein (RIJV). This cannula was connected to the circuit
branch from the original returning cannula (Fig. 1). The
proportion of blood flow that returned to the right FA
and RIJV was initially set as 2.0 L/min and 2.0 L/min, re-
spectively. We then gradually shifted the blood from the
FA to the RIJV over 24 h with frequent evaluation of
blood pressure, right radial arterial oxygenation and left
ventricular ejection fraction (Fig. 2). With a complete shift
of return flow to the RIJV after 25 VAV ECMO hours,
blood pressure (128/92 mmHg), heart rate (96 bpm), lac-
tate level (3.2 mmol/L), and left ventricular ejection frac-
tion (64 %) were stable. Arterial blood gases still showed
respiratory acidosis (pH, 7.321; PaO2, 56.6 Torr, PaCO2,
60.0 Torr; HCO3
−, 30.1 mmol/L).
Despite sustained management with VV ECMO, the
patient died of sepsis on day 47.Discussion
This is the first report of pediatric cardiorespiratory fail-
ure that was managed with VAV ECMO. Transition from
VA ECMO to VV ECMO was successfully performed by
transposing VAV ECMO. The findings of our case indi-
cate the clinical utility of VAV ECMO in combined car-
diorespiratory failure.
Fig. 1 Overview of venoarterial-venous extracorporeal membrane
oxygenation. a Photograph showing a return cannula to the right
internal jugular vein; b a return cannula to the right femoral artery;
and c a drainage cannula from the right femoral vein
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monary failure is occasionally difficult when respiratory
failure persists after recovery of ventricular function. VA
ECMO itself can cause pulmonary injury because of left
ventricular dysfunction and disturbed aortic valve open-
ing due to retrograde blood flow of ECMO. This may in-
duce pulmonary edema and aortic root thrombosis [4].
Decreased pulmonary oxygenation impairs coronary
and/or brain oxygen delivery when native cardiac output
increases, negatively affecting an improvement in cardiac
function. In such cases, transition from VA to VV
ECMO via VAV ECMO may be considered to maintain
oxygenation of the myocardium. Hou et al. investigated
blood oxygenation in the different ECMO configurations
using a sheep model of acute respiratory distress syn-
drome [5]. Blood oxygen saturation of the superior vena
cava (41 %) was lower than that of the IVC (83 %) when
using VA ECMO from the IVC to the FA. Oxygen satur-
ation in the IVC was increased to 76 % in the VAV
ECMO configuration from the IVC to the FA with an
additional return cannula to the internal jugular vein.
Additionally, oxygen saturation in the superior vena cava
was 87 %. These findings suggest better coronary oxy-
genation in VAV ECMO than VA ECMO, although dif-
ferential hypoxia during VA ECMO is dependent on
cardiac output and pulmonary function.
Weaning from VA ECMO in pediatrics is challenging
because of the following reasons. (1) Estimation for recov-
ery in cardiac function while on VA ECMO is relatively
difficult because of a lack of sufficient monitoring, includ-
ing a pulmonary arterial catheter. (2) Hemodynamic
support using intraaortic balloon pumping is usually
inefficient because of high vascular compliance [6]. (3) Re-VAV V-V
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blood access. In addition, survival after second-run ECMO
in children is worse compared with single-run ECMO [7].
In such cases, bridging on VAV ECMO may provide grad-
ual and safer weaning by ensuring sufficient time to evalu-
ate hemodynamic parameters and cardiac function [3].
Although it is not really evident, whether the transition
from VA to VV ECMO via VAV ECMO was really neces-
sary in our patient, this transition at least provided enough
time for safely and definitely evaluating cardiac function
in our patient. Arterial and venous return flows can be
strictly titrated with the use of vascular clamps, while
evaluating native cardiac function [8]. Biscotti et al.
recommended setting initial blood flow to the arterial
return cannula as two-thirds of the total return flow.
Return flow can then be decreased depending on the
native cardiac function until blood flow of 1 L/min to
avoid thrombosis [8].
Conclusions
In conclusion, we described a pediatric patient with car-
diorespiratory failure who was managed with femoral
VAV ECMO. VAV ECMO might be an option for safely
transitioning from VA to VV ECMO by maintaining ad-
equate cardiac oxygenation and allowing for gradual tran-
sition. Further investigations using larger cohorts are
necessary to validate the efficacy of VAV ECMO as a
bridging therapy in the transition from VA to VV ECMO.
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